Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.275
+0.165 (7.82%)
Apr 1, 2026, 11:27 AM EDT - Market open
Nkarta Market Cap
Nkarta has a market cap or net worth of $162.19 million as of April 1, 2026. Its market cap has increased by 38.45% in one year.
Market Cap
162.19M
Enterprise Value
-49.44M
1-Year Change
38.45%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $162.19M, a decrease of -88.92%. That is a compound annual growth rate of -31.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 142.58M | 8.51% |
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Achieve Life Sciences | 153.86M |
| Jyong Biotech | 151.49M |
| Connect Biopharma Holdings | 150.94M |
| Zentalis Pharmaceuticals | 148.93M |
| Artiva Biotherapeutics | 148.79M |
| Cibus | 148.54M |
| Precision BioSciences | 147.34M |
| Codexis | 147.21M |